Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Changes in the blood-brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: a longitudinal study.

Lee JE, Song SK, Hong JY, Sunwoo MK, Park HJ, Sohn YH, Lee PH.

Parkinsonism Relat Disord. 2013 Apr;19(4):450-2. doi: 10.1016/j.parkreldis.2012.12.002. Epub 2013 Jan 5.

PMID:
23298807
[PubMed - indexed for MEDLINE]
2.

Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy.

Song SK, Lee SK, Lee JJ, Lee JE, Choi HS, Sohn YH, Lee PH.

Neurobiol Aging. 2011 Dec;32(12):2183-9. doi: 10.1016/j.neurobiolaging.2009.12.017. Epub 2010 Feb 10.

PMID:
20149484
[PubMed - indexed for MEDLINE]
3.

Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study.

Pellecchia MT, Barone P, Vicidomini C, Mollica C, Salvatore E, Ianniciello M, Liuzzi R, Longo K, Picillo M, De Michele G, Filla A, Brunetti A, Salvatore M, Pappatà S.

Mov Disord. 2011 Jun;26(7):1303-9. doi: 10.1002/mds.23601. Epub 2011 Apr 5.

PMID:
21469200
[PubMed - indexed for MEDLINE]
4.

Uric acid as a potential disease modifier in patients with multiple system atrophy.

Lee JE, Song SK, Sohn YH, Lee PH.

Mov Disord. 2011 Jul;26(8):1533-6. doi: 10.1002/mds.23556. Epub 2011 May 3.

PMID:
21542015
[PubMed - indexed for MEDLINE]
5.

Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study.

Brenneis C, Egger K, Scherfler C, Seppi K, Schocke M, Poewe W, Wenning GK.

J Neurol. 2007 Feb;254(2):191-6.

PMID:
17334661
[PubMed - indexed for MEDLINE]
6.

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.

Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.

J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):773-80.

PMID:
11385012
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study.

Takado Y, Igarashi H, Terajima K, Shimohata T, Ozawa T, Okamoto K, Nishizawa M, Nakada T.

Mov Disord. 2011 Jun;26(7):1297-302. doi: 10.1002/mds.23550. Epub 2011 Mar 2.

PMID:
21370263
[PubMed - indexed for MEDLINE]
8.

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

Rudick RA, Lee JC, Nakamura K, Fisher E.

J Neurol Sci. 2009 Jul 15;282(1-2):106-11. doi: 10.1016/j.jns.2008.11.018. Epub 2008 Dec 19.

PMID:
19100997
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A randomized trial of mesenchymal stem cells in multiple system atrophy.

Lee PH, Lee JE, Kim HS, Song SK, Lee HS, Nam HS, Cheong JW, Jeong Y, Park HJ, Kim DJ, Nam CM, Lee JD, Kim HO, Sohn YH.

Ann Neurol. 2012 Jul;72(1):32-40. doi: 10.1002/ana.23612.

PMID:
22829267
[PubMed - indexed for MEDLINE]
10.

Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).

Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba JP, Ulmer H, Pellecchia MT, Barone P, Kim HT, Hooker J, Quinn NP, Cardozo A, Tolosa E, Abele M, Klockgether T, Østergaard K, Dupont E, Schimke N, Eggert KM, Oertel W, Djaldetti R, Poewe W; European MSA Study Group.

Mov Disord. 2006 Feb;21(2):179-86.

PMID:
16161136
[PubMed - indexed for MEDLINE]
11.

Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment.

Köllensperger M, Stampfer-Kountchev M, Seppi K, Geser F, Frick C, Del Sorbo F, Albanese A, Gurevich T, Giladi N, Djaldetti R, Schrag A, Low PA, Mathias CJ, Poewe W, Wenning GK.

Eur J Neurol. 2007 Jan;14(1):66-72.

PMID:
17222116
[PubMed - indexed for MEDLINE]
12.

Changes in network activity with the progression of Parkinson's disease.

Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D.

Brain. 2007 Jul;130(Pt 7):1834-46. Epub 2007 Apr 30.

PMID:
17470495
[PubMed - indexed for MEDLINE]
Free Article
13.

Cerebral atrophy in multiple system atrophy by MRI.

Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, Goto A, Ito Y.

J Neurol Sci. 2000 Feb 15;173(2):109-12.

PMID:
10675653
[PubMed - indexed for MEDLINE]
14.

MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects.

Paviour DC, Price SL, Lees AJ, Fox NC.

J Neurol. 2007 Apr;254(4):478-81. Epub 2007 Mar 31.

PMID:
17401522
[PubMed - indexed for MEDLINE]
15.

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K.

Clin Pharmacol Ther. 2008 May;83(5):723-30. Epub 2007 Sep 26.

PMID:
17898702
[PubMed - indexed for MEDLINE]
16.

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(8):e22293. doi: 10.1371/journal.pone.0022293. Epub 2011 Aug 4.

PMID:
21829612
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development.

Martola J, Stawiarz L, Fredrikson S, Hillert J, Bergström J, Flodmark O, Kristoffersen Wiberg M.

J Neurol Neurosurg Psychiatry. 2007 Apr;78(4):375-80. Epub 2006 Nov 21.

PMID:
17119006
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group.

Brain. 2010 Aug;133(Pt 8):2382-93. doi: 10.1093/brain/awq158. Epub 2010 Jun 24.

PMID:
20576697
[PubMed - indexed for MEDLINE]
Free Article
19.

Blood-brain barrier permeability abnormalities in vascular cognitive impairment.

Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, Grossetete M, Shah NJ, Wills J, Qualls C, Rosenberg GA.

Stroke. 2011 Aug;42(8):2158-63. doi: 10.1161/STROKEAHA.110.611731. Epub 2011 Jun 30.

PMID:
21719768
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis.

Zivadinov R, Weinstock-Guttman B, Hashmi K, Abdelrahman N, Stosic M, Dwyer M, Hussein S, Durfee J, Ramanathan M.

Neurology. 2009 Aug 18;73(7):504-10. doi: 10.1212/WNL.0b013e3181b2a706.

PMID:
19687451
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk